EE45 Cost-Effectiveness of Venetoclax in Combination with Rituximab in Relapsed/Refractory Chroniclymphocytic Leukemia in Four Gulf Countries by Hamad, A., Abdaljalil, A., Abdellatif, H.Y., Aladarbeh, Q.T., Al Farsi, K., Alhuraiji, A., Gamaleldin, A.M., Hamadah, A., Ismail, H.A., Osman, H.Y., Siddiqui, M., Taha, R.Y., Tannira, M., Pandita, R.

Get full text